Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Avorn

Showing results (21-30 of 436) with videos related to

Pageof 44
Sort By:
The New England Journal of Medicine|December 14, 2011
Learning about the safety of drugs--a half-century of evolutionJerry Avorn
The New England Journal of Medicine|November 30, 2007
In defense of pharmacoepidemiology--embracing the yin and yang of drug researchJerry Avorn
Nature Clinical Practice. Cardiovascular Medicine|May 16, 2007
Does adherence to medical therapy improve long-term survival after myocardial infarction?Jerry Avorn
Medgenmed : Medscape General Medicine|April 17, 2007
Every clinician deserves an un-sales repJerry Avorn
ACP Journal Club|November 4, 2006
Review: good adherence (compared with poor adherence) to drug therapy is associated with a reduction in mortalityJerry Avorn
The New England Journal of Medicine|June 24, 2005
Torcetrapib and atorvastatin--should marketing drive the research agenda?Jerry Avorn
Archives of Internal Medicine|May 26, 2010
Transforming trial results into practice change: the final translational hurdle: Comment on "Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use"Jerry Avorn
BMJ (Clinical Research Ed.)|November 4, 2010
Regulation of devicesJerry Avorn
Annals of Internal Medicine|February 17, 2015
Rethinking the use of physicians as hired expert lecturers--responseJerry Avorn
The New England Journal of Medicine|April 1, 2011
Teaching clinicians about drugs--50 years later, whose job is it?Jerry Avorn
Pageof 44

Showing results (21-30 of 436) with videos related to

Sort By:
Pageof 44
The New England Journal of Medicine|December 14, 2011
Learning about the safety of drugs--a half-century of evolutionJerry Avorn
The New England Journal of Medicine|November 30, 2007
In defense of pharmacoepidemiology--embracing the yin and yang of drug researchJerry Avorn
Nature Clinical Practice. Cardiovascular Medicine|May 16, 2007
Does adherence to medical therapy improve long-term survival after myocardial infarction?Jerry Avorn
Medgenmed : Medscape General Medicine|April 17, 2007
Every clinician deserves an un-sales repJerry Avorn
ACP Journal Club|November 4, 2006
Review: good adherence (compared with poor adherence) to drug therapy is associated with a reduction in mortalityJerry Avorn
The New England Journal of Medicine|June 24, 2005
Torcetrapib and atorvastatin--should marketing drive the research agenda?Jerry Avorn
Archives of Internal Medicine|May 26, 2010
Transforming trial results into practice change: the final translational hurdle: Comment on "Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use"Jerry Avorn
BMJ (Clinical Research Ed.)|November 4, 2010
Regulation of devicesJerry Avorn
Annals of Internal Medicine|February 17, 2015
Rethinking the use of physicians as hired expert lecturers--responseJerry Avorn
The New England Journal of Medicine|April 1, 2011
Teaching clinicians about drugs--50 years later, whose job is it?Jerry Avorn
Pageof 44